Aurinia Pharmaceuticals, Inc. (AUPH)
15.60
+0.07
(+0.45%)
USD |
NASDAQ |
Dec 10, 13:58
Aurinia Pharmaceuticals Market Cap: 2.057B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Halozyme Therapeutics, Inc. | 7.322B |
| Oncolytics Biotech, Inc. | 103.29M |
| Edesa Biotech, Inc. | 12.44M |
| Lexaria Bioscience Corp. | 25.56M |
| Xenon Pharmaceuticals, Inc. | 3.355B |
Market Cap Related Metrics
| PE Ratio | 27.80 |
| PS Ratio | 8.281 |
| Price to Book Value | 5.623 |
| Price to Free Cash Flow | 18.28 |
| Price | 15.60 |
| Earnings Yield | 3.60% |
| Operating PE Ratio | 22.67 |
| Normalized PE Ratio | 24.30 |